Successful allogeneic hematopoietic stem cell transplatation using triple agent immunosuppression in severe aplastic anemia patients

Bone Marrow Transplantation

Volumn 31, Issue 2, 2003, Pages 79-86

  Kim, H J ^a   Park, C Y ^a   Park, Y H ^a   Kim, Y J ^a   Kim, D W ^a   Min, W S ^a   Kim, C C ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

HSCT; Procarbazine; Rejection; SAA; Transfussion

Indexed keywords

CD34 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; METHOTREXATE; PROCARBAZINE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; APLASTIC ANEMIA; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CELL COUNT; CELL SELECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DONOR; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LEUKAPHERESIS; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT CARE; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SIBLING; T LYMPHOCYTE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; BLOOD TRANSFUSION; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVING DONORS; MALE; MIDDLE AGED; PROBABILITY; RETROSPECTIVE STUDIES; SIBLINGS; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0037281186     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703786     Document Type: Review

References (28)

1. Camitta BM, Thomas ED, Nathan DG et al. A Prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979; 53: 504-514.
2. Speck B, Gluckman E, Haak HL, van Rood JJ. Treatment of aplastic anemia by antithymocyte globulin with and without allogeneic bone-marrow infusions. Lancet 1977; iv: 1145-1148.
3. Bacigalupo A, Broccia G, Corda G et al. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 1995; 85: 1348-1353.
4. Thomas ED, Storb R, Giblett ER et al. Recovery from aplastic anemia following attempted marrow transplantation. Exp Hematol 1976; 4: 97-102.
5. Wright SE, Thomas ED, Buckner CD et al. Experience with second marrow transplants. Exp Hematol 1976; 4: 221-226.
6. Meuwissen HJ, Moore EC, Strauss HS et al. Successful retransplantation of bone marrow following failure of initial engraftment in a patient with aplastic anemia. J Pediatr 1976; 89: 588-592.
7. Storb R, Thomas ED, Weiden PL et al. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. Blood 1976; 48: 817-841.
8. Gluckman E, Horowitz MM, Champlin RE et al. Bone Marrow Transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 1992; 79: 269-275.
9. Arranz R, Otero MJ, Ramos R et al. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy. Bone Marrow Transplant 1994; 13: 383-387.
10. Deeg HJ, Leisenring W, Storb R et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 1998; 91: 3637-3645.
11. Bacigalupo A, Oneto R, Bruno B et al. Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for blood and marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation. Acta Haematol 2000; 103: 19-25.
12. Ball SE. The modern management of severe aplastic anaemia. Br J Haematol 2000; 110: 41-53.
13. Passweg JR, Socie G, Hinterberger W et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved?. Blood 1997; 90: 858-864.
14. Storb R, Blume KG, O'Donnell MR et al. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centers. Biol Blood Marrow Transplant 2001; 7: 39-44.
15. Weiden PL, Storb R, Thomas ED et al. Preceding transfusions and marrow graft rejection in dogs and man. Transplant Proc 1976; 8: 551-554.
16. Bacigalupo A. Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European blood and marrow transplantation Group. Eur J Haematol 1996; 60(Suppl.): 16-19.
17. May WS, Sensenbrenner LL, Burns WH et al. BMT for severe aplastic anemia using cyclosporine. Bone Marrow Transplant 1993; 11: 459-464.
18. Young NS, Maciejewsi J. The pathophysiology of acquired aplastic anemia. N Engl J Med 1997; 336: 1365-1372.
19. Young NS. Autoimmunity and its treatment in aplastic anemia. Ann Intern Med 1997; 126: 166-168.
20. Herrera-Garza J, Jaime-Perez J, Montermayor J et al. High-dose peripheral blood stem cell transplant for multitransfused severe aplastic anaemia patients without antithymocyte globulin in the conditioning regimen. Bone Marrow Transplant 1999; 24: 845-848.
21. Naparstek E, Delukina M, Or R et al. Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies. Exp Hematol 1999; 27: 1210-1218.
22. Dufour C, Dallorso S, Casarino L et al. Late graft failure 8 years after first bone marrow transplantation for severe acquired aplastic anemia. Bone Marrow Transplant. 1999; 23: 743-745.
23. Thomas ED, Storb R, Giblett ER et al. Recovery from aplastic anemia following attempted marrow transplantation. Exp Hematol 1976; 4: 97-102.
24. Parkman R, Rappeport J, Camitta B et al. Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients. Blood 1978; 52: 1163-1169.
25. Gluckman E, Horowitz MM, Champlin RE et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 1992; 79: 269-275.
26. Min CK, Kim DW, Lee JW et al. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation. Acta Haematol 2000; 104: 185-192.
27. Min CK, Kim DW, Lee JW et al. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose. Haematologica 2001; 86: 303-310.
28. Min CK, Kim DW, Lee JW et al. Supplemental peripheral blood stem cells to decrease marrow rejection in adult patients with severe aplastic anemia. Am J Hematol 2002; 69: 15-22.